A 24-week randomized, double-blind, placebo-controlled study of the efficacy and tolerability of TNFR: Fc (etanercept) in the treatment of dementia of the Alzheimer type

被引：0
|
作者：
Bohac, D [1 ]
Burke, W [1 ]
Cotter, R [1 ]
Zheng, J [1 ]
Potter, J [1 ]
机构：
[1] Howard Gendelman Univ Nebraska, Med Ctr, Omaha, NE USA
来源：
NEUROBIOLOGY OF AGING | 2002年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
315
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [21] Potentized estrogen in homeopathic treatment of endometriosis-associated pelvic pain: A 24-week, randomized, double-blind, placebo-controlled study
    Teixeira, Marcus Zulian
    Podgaec, Sergio
    Baracat, Edmund Chada
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 211 : 48 - 55
  • [22] A randomized, double-blind, placebo-controlled study of the efficacy and tolerability of policosanol in adolescents with type II hypercholesterolemia
    Castaño, G
    Más, R
    Fernández, L
    Illnait, J
    Hernández, E
    Fernández, JC
    Gámez, R
    Gutiérrez, C
    Alvarez, E
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2002, 63 (04): : 286 - 303
  • [23] Etanercept in the treatment of ankylosing spondylitis: A randomized, double-blind, placebo-controlled study.
    Gorman, JD
    Sack, KE
    Davis, JC
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S403 - S403
  • [24] Methanesulfonyl fluoride (MSF): A double-blind, placebo-controlled study of safety and efficacy in the treatment of senile dementia of the Alzheimer type
    Moss, DE
    Berlanga, P
    Hagan, MM
    Sandoval, H
    Ishida, C
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1999, 13 (01): : 20 - 25
  • [25] Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study
    Kohji Shirai
    Toru Fujita
    Michitaka Tanaka
    Yuka Fujii
    Masatsugu Shimomasuda
    Soichi Sakai
    Yoshishige Samukawa
    Advances in Therapy, 2019, 36 : 86 - 100
  • [26] Empagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial
    Haering, Hans-Ulrich
    Merker, Ludwig
    Seewaldt-Becker, Elke
    Weimer, Marc
    Meinicke, Thomas
    Broedl, Uli C.
    Woerle, Hans J.
    DIABETES CARE, 2014, 37 (06) : 1650 - 1659
  • [27] Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study
    Shirai, Kohji
    Fujita, Toru
    Tanaka, Michitaka
    Fujii, Yuka
    Shimomasuda, Masatsugu
    Sakai, Soichi
    Samukawa, Yoshishige
    ADVANCES IN THERAPY, 2019, 36 (01) : 86 - 100
  • [28] EFFICACY AND SAFETY OF ROMILKIMAB IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC): RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 24-WEEK, PROOF OF CONCEPT STUDY
    Allanore, Y.
    Wung, P.
    Soubrane, C.
    Esperet, C.
    Frederic, M.
    Bejuit, R.
    Lahmar, A.
    Khanna, D.
    Denton, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 157 - 158
  • [29] A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease - Pilot Study
    Prasher, VP
    Huxley, A
    Haque, MS
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 17 (03) : 270 - 278
  • [30] Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: Results from a 24-week, double-blind, placebo-controlled, Randomized trial
    Homma, Akira
    Imai, Yukimichi
    Tago, Hisao
    Asada, Takashi
    Shigeta, Masahiro
    Iwamoto, Toshihiko
    Takita, Masashi
    Arimoto, Itaru
    Koma, Hiroshi
    Ohbayashi, Toshio
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 25 (05) : 399 - 407
12345